While the Boston R&D Hub is relatively young compared to the nearly century-long history of UCB, it represents a continuation and extension of the UCB legacy and our Patient Value Strategy. Read from UCB's Dr. Roger Palframan, Head of External Innovation & U.S. Discovery, on UCB's expanding presence in Boston, Massachusetts and our growing team of talented researchers focused on developing next-generation therapies.

This week, UCB will present at AES2020, the American Epilepsy Society’s (AES) virtual meeting – one of the largest meetings of researchers, scientists, and advocacy groups in the field – where we are proud to showcase the work we have been doing with and on behalf of the epilepsy community. UCB will showcase 15 scientific posters highlighting the latest research on our epilepsy portfolio and pipeline.

• 15 scientific presentations highlight data on BRIVACT^® (brivaracetam) CV, NAYZILAM^® (midazolam) nasal spray CIV, VIMPAT^® (lacosamide) CV, and others, illustrating UCB’s commitment to developing new treatment options for patients in their treatment journey
• UCB’s VIMPAT, recently approved by the U.S. Food and Drug Administration (FDA) as adjunctive therapy in the treatment of primary generalized tonic-clonic seizures (PGTCS), will be highlighted during virtual symposium featuring expert neurology panel

At UCB, we work to foster an inclusive and open environment within our company culture and are continually creating new opportunities for colleagues to foster diverse connections and advance themselves both professionally and personally. Read more about our employee resource group, Women in Leadership (WiL), which exemplifies this passion through its consistent encouragement and promotion of diversity across different functional areas and teams within UCB. 

During Epilepsy Awareness Month, as part of our commitment to providing solutions that positively impact the lives of patients with neurological conditions, we enthusiastically announce a new initiative with Medisafe – the leading integrated medication management platform, personalized to engage patients and deliver outcomes.  

This National Family Caregivers Month, we honor and thank the many caregivers that selflessly care for their loved ones each day. Kristi Lengyel, UCB’s Head of Healthcare System Strategy, knows firsthand the burden many caregivers feel when a loved one experiences a life or death situation. Read her story. 

UCB and Stanford Medicine have established a multi-year collaboration to enhance patient value for people living with severe diseases.

Michele has lived with tonic-clonic seizures since the age of 28 when she experienced her first seizure while swimming in a pool. This Epilepsy Awareness Month, read about her journey to seizure freedom.